Veterinary medicine European Public Assessment Report (EPAR): Porcilis PCV, adjuvanted inactivated vaccine against porcine circovirus, Revision: 3, Authorised
Related Biotechnology, Pharmaceutical and Healthcare News
Human medicines European Public Assessment Report (EPAR): Prepandrix, prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted), Revision: 7, Authorised
Human medicines European Public Assessment Report (EPAR): Pumarix, pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted), Revision: 2, Authorised
Human medicines European Public Assessment Report (EPAR): Pandemrix, influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (x-179a), Revision: 14, Authorised
Veterinary medicine European Public Assessment Report (EPAR): Zulvac 1 Ovis, inactivated bluetongue virus, serotype 1, Revision: 2, Authorised
Veterinary medicine European Public Assessment Report (EPAR): Zulvac 1 Bovis, inactivated bluetongue virus, serotype 1, Revision: 2, Authorised
Original Article: Veterinary medicine European Public Assessment Report (EPAR): Porcilis PCV, adjuvanted inactivated vaccine against porcine circovirus, Revision: 3, Authorised
NEXT ARTICLE
More From BioPortfolio on "Veterinary medicine European Public Assessment Report (EPAR): Porcilis PCV, adjuvanted inactivated vaccine against porcine circovirus, Revision: 3, Authorised"
Search BioPortfolio:
